Eosinophilic inflammation in COPD: prevalence and clinical characteristics

Singh Dave, Kolsum Umme, Brightling Chris E., Locantore Nicholas, Agusti Alvar, Tal-Singer Ruth

Source: Eur Respir J 2014; 44: 1697-1700
Journal Issue: December
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Singh Dave, Kolsum Umme, Brightling Chris E., Locantore Nicholas, Agusti Alvar, Tal-Singer Ruth. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J 2014; 44: 1697-1700

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Eosinophilic lung disease: clinical features of 25 patients
Source: Eur Respir J 2006; 28: Suppl. 50, 237s
Year: 2006

Bronchiectasis prevalence and relationship with clinical features in COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015

Eosinophilic inflammation and asthma control
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009

The clinical characteristics of eosinophilic chronic obstructive pulmonary disease:A cohort study
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020

Pneumonic and non-pneumonic exacerbations of COPD: Systemic inflammatory response and clinical characteristics
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013

Clinical features of eosinophilic COPD
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020


Eosinophilic refractory inflammation in OCS-dependent severe asthma
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


Eosinophilic bronchitis as a cause of chronic cough: a systematic diagnostic evaluation
Source: Eur Respir J 2002; 20: Suppl. 38, 451s
Year: 2002

Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort
Source: Eur Respir J, 50 (4) 1700853; 10.1183/13993003.00853-2017
Year: 2017



Eosinophilic phenotype classification of patients with asthma and/or COPD in NOVELTY
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021


Eosinophilic COPD
Source: Eur Respir Monogr 2022; 95: 100-118
Year: 2022


Eosinophilic airway inflammation as a complication of COPD, and the usefulness of ICS on these cases
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


LATE-BREAKING ABSTRACT: Eosinophilic inflammation in COPD: During clinical stability and exacerbations. The AERIS study
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015


The importance of eosinophilic inflammation in COPD exacerbations
Source: International Congress 2017 – COPD management
Year: 2017

Severe asthma among adults: Prevalence and clinical characteristics
Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers
Year: 2018



Eosinophilic airway inflammation in COPD and asthma
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008


Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other?
Source: Eur Respir J 2003; 22: 8-13
Year: 2003



Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021


Prevalence and co-morbidity of asthma, chronic bronchitis and emphysema: a pan-European estimation
Source: Eur Respir J 2006; 28: Suppl. 50, 449s
Year: 2006

Conclusion: clinical phenotypes of asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005